• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1β和血脂异常综合征是 2 型糖尿病血栓并发症的主要危险因素。

Interleukin-1-beta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitus.

机构信息

Department of Pathophysiology, University of Medicine and Pharmacy Grigore T. Popa, Universităţii Street, No. 16, 700115 Iaşi, Romania.

出版信息

Mediators Inflamm. 2013;2013:169420. doi: 10.1155/2013/169420. Epub 2013 Jan 21.

DOI:10.1155/2013/169420
PMID:23401641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3564383/
Abstract

Diabetes mellitus (DM) is a complex disease characterized by chronic hyperglycemia, a known risk factor for accelerated atherosclerosis and vascular disease. The aim of this study was to show that the connection between DM and other risk factors, such as dyslipidemia, inflammatory phenomena, or the development of certain vascular injuries, leads to a high frequency of thrombotic events in diabetic patients compared to the nondiabetic population. The study included one hundred eighty patients divided in the following groups: diabetic without ischemic cardiopathy-related disorders (DM), diabetic with clinical or off-clinical (electrocardiogram, cardiac ultrasound) ischemic cardiopathy-related disorders (DM + IC), and nondiabetic with ischemic cardiopathy-related disorders (IC). We investigated the following parameters: von Willebrand Factor, HDL-cholesterol, LDL-cholesterol, interleukin-1-beta, protein C, and plasminogen activator inhibitor type 1. The results achieved in our study have revealed the highest thrombotic risk among the groups of diabetic patients, which is in direct correlation with the high values of interleukin-1-beta and the modifications of lipid parameters, acknowledging the data in the literature, according to which hyperglycemia alters endothelial functions directly and indirectly by synthesis of growth factors and cytokines and generates metabolic disorders which would explain the high risk for thrombotic events.

摘要

糖尿病(DM)是一种复杂的疾病,其特征为慢性高血糖,已知这是加速动脉粥样硬化和血管疾病的风险因素。本研究旨在表明,DM 与其他风险因素(如血脂异常、炎症现象或某些血管损伤的发展)之间的联系,导致与非糖尿病患者相比,糖尿病患者发生血栓事件的频率更高。该研究纳入了 180 名患者,分为以下几组:无缺血性心脏病相关疾病的糖尿病患者(DM)、有临床或非临床(心电图、心脏超声)缺血性心脏病相关疾病的糖尿病患者(DM + IC)和有缺血性心脏病相关疾病的非糖尿病患者(IC)。我们研究了以下参数:血管性血友病因子、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、白细胞介素-1-β、蛋白 C 和纤溶酶原激活物抑制剂 1。我们的研究结果表明,糖尿病患者的血栓形成风险最高,这与白细胞介素-1-β和脂质参数的变化直接相关,证实了文献中的数据,根据这些数据,高血糖通过生长因子和细胞因子的合成直接和间接改变内皮功能,并产生代谢紊乱,这可以解释血栓形成事件的高风险。

相似文献

1
Interleukin-1-beta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitus.白细胞介素-1β和血脂异常综合征是 2 型糖尿病血栓并发症的主要危险因素。
Mediators Inflamm. 2013;2013:169420. doi: 10.1155/2013/169420. Epub 2013 Jan 21.
2
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.超越低密度脂蛋白:应对2型糖尿病和代谢综合征中的致动脉粥样硬化脂质三联征。
Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005.
3
Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.高密度脂蛋白胆固醇水平在老年IIb型血脂异常糖尿病患者中的重要性:一项为期2年的心血管事件调查
Geriatr Gerontol Int. 2014 Oct;14(4):806-10. doi: 10.1111/ggi.12168. Epub 2013 Nov 12.
4
Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population.低β脂蛋白血症与弗雷明汉后代人群中低水平的止血危险因素相关。
Circulation. 1997 Feb 18;95(4):825-30. doi: 10.1161/01.cir.95.4.825.
5
Apolipoprotein B vs non-high-density lipoprotein cholesterol: Association with endothelial hemostatic markers and carotid intima-media thickness.载脂蛋白B与非高密度脂蛋白胆固醇:与内皮止血标志物及颈动脉内膜中层厚度的关联
J Clin Lipidol. 2017 Mar-Apr;11(2):442-449. doi: 10.1016/j.jacl.2017.01.020. Epub 2017 Feb 10.
6
Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.姜黄素类化合物对2型糖尿病患者血脂的影响:一项随机对照试验。
Complement Ther Med. 2017 Aug;33:1-5. doi: 10.1016/j.ctim.2017.05.006. Epub 2017 May 29.
7
Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.泰国全国性研究:糖尿病患者并发症相关血脂异常的流行情况。
Lipids Health Dis. 2019 Apr 6;18(1):90. doi: 10.1186/s12944-019-1034-3.
8
Positive Correlation of Serum Adiponectin with Lipid Profile in Patients with Type 2 Diabetes Mellitus is Affected by Metabolic Syndrome Status.2型糖尿病患者血清脂联素与血脂谱的正相关受代谢综合征状态影响。
Arch Iran Med. 2016 Apr;19(4):269-74.
9
[Diabetic dyslipidaemia and the atherosclerosis].[糖尿病血脂异常与动脉粥样硬化]
Orv Hetil. 2016 May 8;157(19):746-52. doi: 10.1556/650.2016.30441.
10
Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy.高血压和血脂异常患者的炎症生物标志物 CRP、MCP-1、血清淀粉样蛋白α 和白细胞介素-18:糖尿病对代谢综合征的影响以及他汀类药物治疗的效果。
Hypertens Res. 2013 Jun;36(6):550-8. doi: 10.1038/hr.2012.214. Epub 2013 Feb 7.

引用本文的文献

1
Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction.NLRP3炎性小体/IL-1β正反馈回路的药理学阻断减轻内皮细胞衰老和功能障碍。
Aging Dis. 2022 Feb 1;13(1):284-297. doi: 10.14336/AD.2021.0617. eCollection 2022 Feb.
2
Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner?效仿CANTOS试验的变革:糖尿病抗炎治疗即将到来?
Cardiovasc Diabetol. 2017 Jul 19;16(1):91. doi: 10.1186/s12933-017-0573-z.
3
Epigallocatechin gallate attenuates proliferation and oxidative stress in human vascular smooth muscle cells induced by interleukin-1β via heme oxygenase-1.表没食子儿茶素没食子酸酯通过血红素加氧酶-1减轻白细胞介素-1β诱导的人血管平滑肌细胞增殖和氧化应激。
Mediators Inflamm. 2014;2014:523684. doi: 10.1155/2014/523684. Epub 2014 Sep 7.
4
Metabolic consequences of Helicobacter pylori infection and eradication.幽门螺杆菌感染与根除的代谢后果。
World J Gastroenterol. 2014 May 14;20(18):5226-34. doi: 10.3748/wjg.v20.i18.5226.
5
Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.绿茶提取物对2型糖尿病合并血脂异常患者胰岛素抵抗和胰高血糖素样肽1的影响:一项随机、双盲、安慰剂对照试验。
PLoS One. 2014 Mar 10;9(3):e91163. doi: 10.1371/journal.pone.0091163. eCollection 2014.

本文引用的文献

1
Insulin resistance, inflammation, and the prediabetic state.胰岛素抵抗、炎症与糖尿病前期状态。
Am J Cardiol. 2003 Aug 18;92(4A):18J-26J. doi: 10.1016/s0002-9149(03)00612-x.
2
The platelet in diabetes: focus on prevention of ischemic events.糖尿病中的血小板:聚焦缺血性事件的预防
Diabetes Care. 2003 Jul;26(7):2181-8. doi: 10.2337/diacare.26.7.2181.
3
Diabetic dyslipidaemia: from basic research to clinical practice.糖尿病血脂异常:从基础研究到临床实践
Diabetologia. 2003 Jun;46(6):733-49. doi: 10.1007/s00125-003-1111-y. Epub 2003 May 28.
4
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.2型糖尿病与胰岛素抵抗中的动脉粥样硬化:机制联系与治疗靶点
J Diabetes Complications. 2002 Nov-Dec;16(6):401-15. doi: 10.1016/s1056-8727(02)00202-7.
5
Platelet dysfunction in type 2 diabetes.2型糖尿病中的血小板功能障碍。
Diabetes Care. 2001 Aug;24(8):1476-85. doi: 10.2337/diacare.24.8.1476.
6
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.C反应蛋白、白细胞介素6与2型糖尿病发病风险
JAMA. 2001 Jul 18;286(3):327-34. doi: 10.1001/jama.286.3.327.
7
Mechanisms of diabetic vasculopathy: an overview.糖尿病血管病变的机制:综述
Am J Hypertens. 2001 May;14(5 Pt 1):475-86. doi: 10.1016/s0895-7061(00)01323-6.
8
The hormone resistin links obesity to diabetes.抵抗素这种激素将肥胖与糖尿病联系起来。
Nature. 2001 Jan 18;409(6818):307-12. doi: 10.1038/35053000.
9
Insulin resistance and cardiovascular disease.胰岛素抵抗与心血管疾病。
J Clin Invest. 2000 Aug;106(4):453-8. doi: 10.1172/JCI10762.
10
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.使线粒体超氧化物生成正常化可阻断高血糖损伤的三条途径。
Nature. 2000 Apr 13;404(6779):787-90. doi: 10.1038/35008121.